Idexx Laboratories (IDXX) Deferred Taxes (2009 - 2026)

Idexx Laboratories' Deferred Taxes history runs 18 years deep, the most recent figure standing at $13.9 million for Q1 2026.

• In Q1 2026, Deferred Taxes rose 251.82% year-over-year to $13.9 million; the TTM figure through Mar 2026 stood at $141.1 million (up 898.56% YoY), while the FY2025 annual figure was $131.2 million, up 642.3% from the prior year.
• Deferred Taxes was $13.9 million for Q1 2026 at Idexx Laboratories, down from $31.5 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $93.2 million in Q3 2025 to a low of -$33.6 million in Q4 2023.
• Historically, Deferred Taxes has averaged $2.2 million across 5 years, with a median of -$2.6 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Deferred Taxes tumbled 9186.81% in 2022, then surged 1461.48% in 2025.
• A 5-year view of Deferred Taxes shows it stood at $1.8 million in 2022, then slumped by 1938.74% to -$33.6 million in 2023, then surged by 113.93% to $4.7 million in 2024, then surged by 574.27% to $31.5 million in 2025, then plunged by 55.95% to $13.9 million in 2026.
• The last three Deferred Taxes figures came in at $13.9 million (Q1 2026), $31.5 million (Q4 2025), and $93.2 million (Q3 2025), per Business Quant data.